News
1h
Zacks Investment Research on MSNAmgen Looks to Take Share of Booming Obesity Space: Will It Succeed?Amgen AMGN is one of the several drug makers racing to develop the next blockbuster weight loss drug and take a share of the ...
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results